Pharmalot… Pharmalittle… G’Morning, Folks
2 CommentsBy Ed Silverman // April 24th, 2008 // 6:55 am
We apologize for the drought in items yesterday afternoon, but we did something unusual - we took the afternoon off. The schools are closed over here and we promised the short people that we would do something special. And so we did. Of course, we are still sorting out all the events that occurred in our absence. Nonetheless, we are recovering nicely and want to share these with you…
ImClone Posts Loss On Investment Writedown (Reuters)
Wyeth Pulls Europe Application For Pneumonia Drug (Reuters)
Vertex Reports Promising Hep C Drug Data (TheStreet.com)
Schering-Plough Sells Animal Health Meds To Pfizer (Associated Press)
Shire Wins FDA Approval Of Vyvanse In Adults (Bloomberg News)
Glaxo CEO Warns UK Over Tax Changes (The Times Of London)
Biovail Settles Class Action Lawsuit (Reuters)
Novo Nordisk To Expand NJ HQ, Add 400 Jobs (Associated Press)
LILLI
Ed
Please explain the raeson for Pharmalot? Though it may give information, It does help to protect and better patient safety with medications? Many Medications are causing more harm than good—what is the answer to protect the health of all?
Ed Silverman
Lilli,
You’ve asked me this before, and I have answered you each time. Pharmalot is a blog - a place where one can get news, insights and have discussions about pharma topics with folks who share that interest for whatever reason, personal or professional.
The site exists to disseminate information and create a venue where ideas can be exchanged. What happens from there is the same as with any media, new or old, in that discussions can lead to any number of things - people taking action, individually or in groups, to pursue a common goal, or one or more people learning something useful for their lives or work.
What are you expecting?
ed